Introduction Zhejiang Kinglyuan Pharmaceutical Company Limited was founded in 1998, which occupies an area of 160,000 square meters, has a total asset of RMB 260 million and a total staff of 218. After more than ten years´ development, Kinglyuan has become an all-around pharmaceutical enterprise which combines research & development, manufacturing, distribution and service into one. Overview Product Structure Kinglyuan is specialized in research and development of self-IPR´s modern TC drugs, biological drugs, chemical drugs and green health care products, including APIs, intermediates and formulations, who has established an independent, strict and sound quality management system in accordance with GMP. Many products are exported to oversea market. Production Facility Kinglyuan´s facilities are capable of manufacturing a variety of bulk drugs and intermediates which comply with International standards. These facilities, which have a good capacity of production, are well sup